Neowise Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.05 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.00 Cr
- Revenue Growth %
- Profit Growth 10.65%
- Ebitda 3.15%
- Net Worth -45.08%
- Total Assets 61.12%
About Neowise Life Sciences
Neowise Life Sciences Private Limited (NLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2017 (Seven years and ten months 10 days old ). Its registered office is in Daund, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.05 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹44.00 Cr.
Jalindar Padwal and Radish Nair serve as directors at the Company.
Company Details
- Location
Daund, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100PN2017PTC169500
- Company No.
169500
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Neowise Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jalindar Padwal  | Director | 20-Mar-2017 | Current |
| Radish Nair | Director | 22-Apr-2023 | Current |
Financial Performance of Neowise Life Sciences.
Neowise Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 10.65% increase in profit. The company's net worth observed a substantial decline by a decrease of 45.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neowise Life Sciences?
In 2021, Neowise Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Atharva Biopharma Private LimitedJalindar Padwal is a mutual person
- Kaizenair Systems And Services Llp
Radish Nair is a mutual person
- Revaa Associates Llp
Radish Nair is a mutual person
- Revaa Organics Llp
Radish Nair is a mutual person
- Kaizenleap Technologies Private Limited
Radish Nair is a mutual person
Charges (Loans)
₹44.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 44.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2022 | Karnataka Bank Ltd. | ₹44.00 Cr | Open |
How Many Employees Work at Neowise Life Sciences?
Unlock and access historical data on people associated with Neowise Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neowise Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neowise Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
